Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma characterized by the rapid proliferation of B-lymphoid cells. It primarily affects lymph nodes in the head, face, and neck regions. Accurate coding with ICD-10 Code C83.71 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C83.71 specifically denotes Burkitt lymphoma affecting the lymph nodes of the head, face, and neck. This code is utilized in clinical documentation and billing when diagnosing patients with this aggressive lymphoma variant, which requires prompt medical intervention due to its rapid progression and potential complications.
Burkitt lymphoma is a type of B-cell non-Hodgkin lymphoma that is characterized by a high proliferation rate and often presents with lymphadenopathy in the head, face, and neck. The condition is associated with chromosomal translocations involving the MYC gene, leading to uncontrolled cell growth. Early diagnosis and treatment are critical due to its aggressive nature.
ICD-10 Code C83.71 is integral to SOAP notes, facilitating the documentation of symptoms, assessments, and treatment plans for patients diagnosed with Burkitt lymphoma. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code C83.71 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Burkitt lymphoma. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Burkitt lymphoma requires urgent medical intervention, often necessitating hospitalization for intensive treatment. Chemotherapy is the primary treatment modality, and supportive care is essential to manage symptoms and prevent complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.71 is critical for accurate billing in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with automated differential. |
| 77021 | CT scan of the neck for lymphadenopathy. |
Common Questions About Using ICD-10 Code C83.71 for Burkitt lymphoma, lymph nodes of head, face, and neck
What are the common symptoms of Burkitt lymphoma?
Common symptoms include rapidly enlarging lymph nodes, especially in the neck and jaw, fever, night sweats, and unexplained weight loss. Patients may also experience abdominal pain if the lymphoma affects the gastrointestinal tract.
How is Burkitt lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes. Laboratory tests may also be conducted to assess blood counts and tumor markers.
What is the treatment for Burkitt lymphoma?
Treatment primarily involves intensive chemotherapy regimens. In some cases, radiation therapy may be used. Supportive care is also crucial to manage side effects and complications.
Is Burkitt lymphoma contagious?
No, Burkitt lymphoma is not contagious. It is a type of cancer that arises from genetic mutations in B-cells, often associated with viral infections like Epstein-Barr virus, but it cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes